Jan 23, 2008 by Brian Orelli, PhDTeva Buys In to BiologicsTeva buys CoGenesys with its pocket change.
Jan 23, 2008 by Brian Orelli, PhDA Dose of Stability From J&JStellar growth isn't necessary in an awful economy.
Jan 22, 2008 by Brian Orelli, PhDSchering Slows Its SlideAfter the bad Vytorin news, Schering's CEO puts his money where his mouth is.
Jan 22, 2008 by Brian Orelli, PhDThe Little Anti-Inflammatory That CouldAbbott gets yet another approval for Humira.
Jan 18, 2008 by Brian Orelli, PhDThe Battle of the ThrombinsZymoGenetics gets the ref's OK to enter the fray.
Jan 17, 2008 by Brian Orelli, PhDEPIX's Epic OopsThe clinical trial data wasn't as positive as it first appeared.
Jan 16, 2008 by Brian Orelli, PhDHeadache Almost Over for PozenThe drug is safe; hopefully that's all the FDA wanted to know.
Jan 16, 2008 by Brian Orelli, PhDForest Labs Not Down -- YetDouble-digit revenue growth is the highlight of a good quarter.
Jan 15, 2008 by Brian Orelli, PhDNo Enhance-ment From ZetiaMerck and Schering report bad news, but how much will it affect sales?
Jan 15, 2008 by Brian Orelli, PhDIdeal Results From ScheringSchering's hepatitis C drug works as well as Roche's.
Jan 15, 2008 by Brian Orelli, PhDFewer Generics in Fido's FutureTEVA considers selling its animal-health business.
Jan 11, 2008 by Brian Orelli, PhDBoston Scientific Lives Below Its MeansCost-cutting efforts should help turn the company around in 2008.
Jan 11, 2008 by Brian Orelli, PhDFDA Approval Bleeds Omrix's StockWas the approval already built into the stock price?
Jan 11, 2008 by Brian Orelli, PhDBiochip Packaging: Some Settling May OccurIllumina settles its disputes about patents with Affymetrix.
Jan 10, 2008 by Brian Orelli, PhDGood News for Lucky MenEli Lilly's erectile dysfunction drug can now be taken daily.
Jan 9, 2008 by Brian Orelli, PhDGenzyme Buys Into Antisense RNA -- Big TimeGenzyme buys a piece of Isis' mipomersen at a wowser of a price.
Jan 9, 2008 by Brian Orelli, PhDSirtris' Diabetes Drug: Safe, but Is It Effective?Sirtris has exciting drugs, but is still a pretty risky investment.
Jan 8, 2008 by Brian Orelli, PhDBrits May Bludgeon Drug CompaniesHow will a 10% drop in U.K. drug prices hurt the industry?
Jan 8, 2008 by Brian Orelli, PhDA Painful Reminder From the FDAThe agency issues a reminder that osteoporosis drugs can cause severe pain.
